Janus Living, Inc. research snapshot
JAN AI stock analysis currently reads Janus Living, Inc. as the only U.S.-listed REIT focused exclusively on senior housing, with strong Q1 2026 execution, a clean balance sheet, and a valuation that already sits near the consensus price target. As of the August 3, 2026 data cutoff, the stock traded at $30.42 intraday, up 0.70% from the $30.21 close on July 31, with a market capitalization of about $8.77 billion computed as $30.42 times 288.14 million shares outstanding. Q1 2026 revenue grew 35% year over year, same-store NOI rose 13.8%, same-store occupancy reached 88.5%, and entrance fee sales set a record, while the company carried about $950 million of cash and no debt and raised its 2026 guidance. The stock trades at roughly 13.3x trailing revenue and about 31.7x forward FFO, so most of the expected growth is already priced in. The JAN AI stock forecast uses scenario ranges because senior housing REIT valuation depends on occupancy, entrance fees, interest rates, acquisition execution, and the related-party external management relationship with Healthpeak Properties rather than a single predictable path. This page is informational research, not investment advice.
Current price
$30.42 intraday on August 3, 2026, up 0.70% from the $30.21 close on July 31, 2026
Market cap
$8.77 billion, verified as $30.42 x 288.14 million shares outstanding
AI score
60 / 100
Rating
Strong Q1 execution and clean balance sheet at a premium valuation on the only U.S.-listed pure-play senior housing REIT
Trend status
Above the 20-day and 50-day moving averages after a 4.6% five-day pullback, with 14-day RSI near 55
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Janus Living is the only U.S.-listed pure-play senior housing REIT, operating 34 communities with 10,422 units under RIDEA structures across 10 states, with 69% of units in Florida and Texas and 100% SHOP exposure. | Medium-high |
| Moat | The moat is moderate and comes from large-scale continuum-of-care campuses, an entry fee business with high barriers, RIDEA operating partnerships, and focused retirement-market locations. The "only listed pure-play" status and external manager relationships add deal sourcing and distribution advantages. | Medium |
| Management | CEO Scott Brinker and the team delivered a strong Q1 2026 debut with revenue up 35%, same-store NOI up 13.8%, and raised 2026 guidance. The company is externally managed by Healthpeak Properties under a three-year contract, which brings expertise but also related-party and key-person considerations. | Medium-high |
| Financial trend | Q1 2026 revenue grew 35% year over year with 88.5% same-store occupancy and record entrance fee sales. TTM revenue is $655.41 million, FY2025 revenue was $603.99 million, and the company ended Q1 2026 with about $950 million of cash, no debt, and $1.5 billion of available liquidity, though TTM GAAP net income is still near break-even. | Medium-high |
| Valuation | At $30.42, JAN trades near 13.3x trailing revenue, 2.6x book value, 47.9x EV/EBITDA, and about 31.7x forward FFO, which is a premium that requires continued FFO growth and NOI momentum to be justified. | Medium |
| Technical trend | JAN trades above its 20-day and 50-day moving averages but below the 5-day average after a 4.6% five-day pullback from near the 52-week high, with 14-day RSI near 55 and a strong ADX reading near 38. | Medium |
| Risk level | Key risks are geographic concentration with 69% of units in Florida and Texas, a five-month public history, a small float of about 73 million shares, related-party external management by Healthpeak, interest rate sensitivity, entrance fee dependence on housing turnover, and an elevated valuation. | Medium-high |
| AI confidence | High confidence for quote, market cap, share count, Q1 results, balance sheet, analyst targets, and valuation math that cross-checked across StockAnalysis.com, Barchart, and SEC data. Lower confidence for forward price and trend reliability given the short public history. | Medium-high data confidence |
| Investment certainty | Low-medium. Execution is strong and the balance sheet is clean, but the stock already trades near the consensus price target, and the short track record plus concentrated exposure limit conviction. | Low-medium |
JAN AI stock forecast
The JAN AI stock forecast uses scenario ranges around the $30.42 reference price and a 2026 FFO as adjusted consensus of about $0.96 per share. It does not claim that AI can predict a specific future price. The bullish case requires FFO per share to compound at a high-teens to 20% rate through occupancy gains and accretive acquisitions, entrance fee momentum to continue, and the market to keep a premium multiple on the only U.S.-listed pure-play senior housing REIT. The base case assumes mid-teens FFO growth and a multiple near current levels, consistent with the $30.92 consensus target. The bearish case assumes occupancy stalls, Florida or Texas housing markets soften, entrance fee sales normalize down, interest rates pressure REIT multiples, or the premium valuation compresses.
$44 to $52 before dividends
More likely if JAN compounds FFO per share near 15% to 20% annually, same-store NOI stays at or above the 11% to 15% guidance, entrance fee sales keep setting records, the acquisition pipeline closes accretively, and the market sustains a premium multiple on the pure-play senior housing growth story.
$32 to $38 before dividends
More likely if FFO per share grows near 12%, the company executes the planned acquisition closings on schedule, occupancy climbs toward 90%, and the stock holds near the analyst consensus price target of $30.92 with a modest upward drift.
$19 to $24 before dividends
More likely if occupancy growth stalls, Florida or Texas markets soften, entrance fee sales normalize down, interest rates rise and push REIT multiples lower, the acquisition pipeline closes at dilutive yields, or the small float amplifies a de-rating.
JAN AI technical analysis
JAN AI technical analysis as of the August 3, 2026 data cutoff reflects a stock that ran up after the IPO and the Q1 report and has pulled back about 4.6% over five days from near the 52-week high. The stock trades at $30.42 intraday, above the 20-day moving average near $30.19 and the 50-day moving average near $28.10, but below the 5-day moving average near $30.76. Barchart showed a 14-day RSI near 54.7 and an ADX near 38.5 with +DI above -DI, indicating a strong trend with short-term consolidation. Because JAN has less than six months of public trading history, technical levels should be confirmed on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $30.42 | Intraday reading on August 3, 2026, up 0.70% from the $30.21 close on July 31, 2026. Day range was $29.99 to $30.36. |
| Near support | $29.90 to $30.20 | The 20-day moving average area near $30.19 reported by Barchart. The stock has been holding this zone during the pullback. |
| Major support | $28.00 to $28.20 | The 50-day moving average area, about $28.10 on Barchart and $28.03 on StockAnalysis.com. A sustained break below this would weaken the intermediate trend. |
| Deeper support | $26.50 to $27.00 | Near the year-to-date reference of $26.78 and an area that would mark a more serious trend failure after the post-IPO run. |
| Near resistance | $31.00 to $32.00 | The recent consolidation zone before the 52-week high. Barchart showed the 5-day average near $30.76 as an immediate overhead level. |
| 52-week high | $32.83 | The stock pulled back from near this level. A break above it with rising volume would confirm trend continuation. |
| Moving averages | 5-day $30.76, 20-day $30.19, 50-day $28.10 | Barchart showed JAN below the 5-day average, near the 20-day average, and well above the 50-day average as of the August 3, 2026 reading. |
| Momentum | 14-day RSI near 54.7, ADX near 38.5 | RSI is neutral-to-bullish. ADX near 38.5 with +DI at 25.94 above -DI at 18.05 indicates a strong trend with a positive directional bias, even during the short-term pullback. |
| Volume | 20-day average about 1.0 million shares | Average volume is about 1.02 million shares on StockAnalysis.com and 952,202 on Barchart. Breakout or breakdown moves should be confirmed by rising participation. |
| Volatility | 14-day ATR about $0.89 | ATR of about $0.89 represents roughly 2.9% of the stock price. Position sizing should account for this daily movement and for the limited float. |
| Invalidation | Close below $28.10, then below $27.00 | A close below the 50-day area near $28.10 would weaken the intermediate uptrend. A break below $27.00 would challenge the post-IPO uptrend structure. |
JAN AI trading strategy
The JAN AI trading strategy below is a rules-based research framework, not personalized advice. It combines chart levels with occupancy, entrance fee sales, acquisition closings, the related-party external management relationship, interest rate direction, and the next quarterly report on August 4, 2026. Given the small float of about 73 million shares and the short public history, position sizes should be conservative.
Watch for JAN to hold the 20-day area near $30.19 and reclaim the 5-day average near $30.76 with rising volume. A break above $32.83 with a constructive Q2 2026 report on August 4 would confirm continuation of the post-IPO uptrend.
A daily close below the 50-day area near $28.10 should reduce trend confidence, especially if occupancy, entrance fee, or interest rate news surprises negatively.
If JAN pulls back toward the $28.00 to $28.20 support zone while same-store NOI guidance of 11% to 15% and entrance fee momentum stay intact, compare the lower price with forward FFO, the analyst target range of $28 to $34, and the balance sheet strength.
Do not add to a position solely because the stock is a recent IPO or because it has fallen. Define maximum exposure relative to the small float, and watch the August 4 earnings date for volatility.
Track Q2 2026 results on August 4, 2026, same-store occupancy and NOI margins, entrance fee sales, acquisition pipeline closings, dividend coverage near a 20% FFO payout ratio, and interest rate direction.
Lower the rating if same-store NOI growth slows below guidance, occupancy rolls over, entrance fee momentum fades, acquisitions close at dilutive yields, or the company needs external capital at unfavorable prices.
Investment research summary
Residents and their families pay Janus Living for premium senior housing with entrance fees and monthly fees across large continuum-of-care communities. The RIDEA structure keeps the REIT asset-light on operations while it captures NOI from 34 communities in 10 states.
The moat is moderate and comes from large-scale life plan campuses, entry fee pricing power with high barriers to entry, RIDEA operating partnerships, focused retirement markets, and the status of being the only U.S.-listed pure-play senior housing REIT.
The thesis fails if Florida or Texas markets soften, occupancy growth stalls, entrance fee sales normalize down, interest rates push REIT multiples lower, the acquisition pipeline closes at dilutive yields, or the related-party external management relationship creates misalignment.
Scott Brinker and the team executed a strong Q1 2026 debut and raised guidance. The company is externally managed by Healthpeak Properties under a three-year contract, which brings expertise and deal flow but also related-party and key-person considerations that a longer public track record would help resolve.
Senior housing sits in a long-term demographic tailwind as the 75-plus population grows, construction costs constrain new supply, and occupancy recovers from prior weakness. The entry fee business adds a differentiated growth driver, but the sector remains sensitive to housing turnover, interest rates, and labor costs.
At about 13.3x trailing revenue and 31.7x forward FFO, the stock prices in strong FFO growth and trades near the $30.92 consensus price target. The margin of safety is thin until the growth and the acquisition pipeline are proven over a longer public track record.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| JAN quote reference | $30.42 intraday on August 3, 2026, up 0.70% from the $30.21 July 31 close, with a day range of $29.99 to $30.36 and a 52-week range of $22.76 to $32.83 | StockAnalysis.com JAN overview | August 3, 2026 |
| Market capitalization verification | $8.77 billion reported and $8.77 billion calculated from $30.42 x 288.14 million shares, with 0.05% variance | Pineify financial_rigor.py and StockAnalysis.com | August 3, 2026 |
| Shares outstanding and float | 288.14 million shares outstanding; current share class about 212.22 million; float about 73.09 million; insiders own 0.15% and institutions 92.25% | StockAnalysis.com JAN statistics | August 3, 2026 |
| Enterprise value | $7.76 billion | StockAnalysis.com JAN statistics | August 3, 2026 |
| Revenue trend | TTM revenue of $655.41 million; FY2025 revenue of $603.99 million up 6.25%; FY2024 revenue of $568.48 million | StockAnalysis.com JAN income statement | August 3, 2026 |
| Net income and FFO | TTM net income of about -$97 thousand (near break-even); FY2025 net income of $6.35 million; TTM FFO of $149.99 million; FY2025 FFO of $151.8 million | StockAnalysis.com JAN income statement | August 3, 2026 |
| Q1 2026 results | Q1 2026 consolidated revenue up 35% year over year, adjusted EBITDA up 42%, FFO as adjusted per share up 35%, same-store revenue up 7.6%, same-store NOI up 13.8%, same-store occupancy of 88.5%, and 2026 FFO as adjusted guidance of $0.93 to $0.97 | Janus Living Q1 2026 earnings release and call transcript | May 6, 2026 |
| Balance sheet snapshot | Cash and equivalents of $948.82 million, no debt, net cash of $948.82 million or $3.29 per share, shareholders equity of $3.05 billion, and total assets of $4.02 billion as of March 31, 2026 | StockAnalysis.com JAN balance sheet and statistics | August 3, 2026 |
| Dividend data | Annualized dividend of $0.57 per share, 1.89% yield, paid monthly; next ex-dividend date August 14, 2026; FFO payout ratio near 20% | StockAnalysis.com JAN dividend history | August 3, 2026 |
| Valuation math | 13.38x P/S computed (13.28x reported), 2.63x P/B computed (2.61x reported), 1.87% dividend yield computed (1.89% reported), and 47.95x EV/EBITDA computed (47.93x reported) | Pineify financial_rigor.py and StockAnalysis.com | August 3, 2026 |
| Analyst consensus forecast | Consensus rating Buy from 12 analysts, average price target of $30.92 (range $28 to $34, median $30), FY2026 revenue estimate of $883.89 million up 46%, and FY2026 FFO estimate of $243.31 million or about $0.96 per share | StockAnalysis.com JAN forecast | July 15, 2026 |
| Recent analyst actions | Wells Fargo raised its target to $33 from $31 on July 15, 2026; Barclays raised to $33 from $30 on July 7, 2026; J.P. Morgan raised to $30 from $26; Raymond James initiated with $34; Scotiabank lowered to $29 from $30 | StockAnalysis.com JAN forecast and TheFly | July 15, 2026 |
| Technical references | 5-day moving average $30.76, 20-day moving average $30.19, 50-day moving average $28.10, 14-day RSI 54.66, ADX 38.49 with +DI 25.94 above -DI 18.05, 14-day ATR $0.89, and 14-day historic volatility 26.81% | Barchart JAN technical analysis | August 3, 2026 |
| Short interest | 4.69 million shares sold short, equal to 1.63% of shares outstanding, 6.42% of float, and about 2.65 days to cover | StockAnalysis.com JAN statistics | August 3, 2026 |
| IPO and offering history | IPO on March 20, 2026 at $20.00 per share; a June 2026 offering of 25 million Class A-1 shares priced at $25.00; Healthpeak Properties remains the external manager | StockAnalysis.com JAN company profile and TheFly | August 3, 2026 |
| Next earnings date | Q2 2026 earnings expected on August 4, 2026 after market close | StockAnalysis.com JAN overview | August 3, 2026 |
This JAN AI stock analysis page is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of return. Forecast scenarios are based on available public data as of August 3, 2026 and can be wrong if occupancy, entrance fee sales, interest rates, acquisition execution, the related-party external management relationship, or other company and market conditions change. JAN is a recently listed company with a limited public trading history, which increases uncertainty beyond what typical stock analysis can capture.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
